STATE STREET CORP - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 46 filers reported holding OVID THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,258,787
+26.5%
1,109,059
+8.0%
0.00%
Q2 2023$3,367,350
+580.7%
1,026,631
+435.4%
0.00%
Q1 2023$494,671
-30.6%
191,733
-50.0%
0.00%
Q4 2022$713,246
+102.1%
383,466
+100.0%
0.00%
Q3 2022$353,000
-14.3%
191,7330.0%0.00%
Q2 2022$412,000
-31.6%
191,7330.0%0.00%
Q1 2022$602,000
+29.5%
191,733
+32.4%
0.00%
Q4 2021$465,000
-4.5%
144,8490.0%0.00%
Q3 2021$487,000
-20.6%
144,849
-7.7%
0.00%
Q2 2021$613,000
-87.3%
156,849
-87.0%
0.00%
Q1 2021$4,842,000
+183.5%
1,204,365
+62.9%
0.00%
Q4 2020$1,708,000
-59.1%
739,440
+1.7%
0.00%
Q3 2020$4,174,000
-23.0%
727,232
-1.2%
0.00%
Q2 2020$5,424,000
+1528.8%
735,956
+291.6%
0.00%
Q1 2019$333,000
-19.0%
187,915
+10.7%
0.00%
Q4 2018$411,000
-60.5%
169,815
-7.6%
0.00%
Q3 2018$1,041,000
-5.2%
183,764
+30.6%
0.00%
Q2 2018$1,098,000
+47.0%
140,744
+33.1%
0.00%
Q1 2018$747,000
-0.1%
105,728
+39.9%
0.00%
Q4 2017$748,000
+21.4%
75,566
+5.0%
0.00%
Q3 2017$616,000
+18.5%
71,935
+45.0%
0.00%
Q2 2017$520,00049,6000.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
AWH Capital, L.P. 230,000$407,0000.69%
BVF INC/IL 3,293,000$5,829,0000.65%
COWEN INC. 1,101,414$1,950,0000.21%
ARMISTICE CAPITAL, LLC 1,780,000$3,151,0000.17%
Granite Point Capital Management, L.P. 417,857$740,0000.07%
Redmile Group, LLC 737,550$1,305,0000.04%
Tekla Capital Management LLC 496,977$880,0000.04%
Fairpointe Capital LLC 101,000$179,0000.01%
Alyeska Investment Group, L.P. 225,000$398,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,440$149,0000.00%
View complete list of OVID THERAPEUTICS INC shareholders